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ONLINE SUPPLEMENT 
Materials and methods 
Generation of recombinant constructs A, H, AH, AHC and AHHC 
The construct A contains an epitope derived from human ApoB100 (peptide sequence: 
I
688
EIGLEGKGFEPTLEALFGK
707
, numbered including signal peptide) incorporated into the N-terminal 
of dendroaspin with a poly-glycine linker between ApoB peptide and dendroaspin. Schematic 
representation of the backbone of the dendroaspin structure is shown in Figure S1A [1]. Construct H 
incorporates an epitope of hHSP60 (peptide sequence: A
153
ELKKQSKPVT
163
) in dendroaspin loop III as 
a replacement of wild-type loop III sequence. Construct AH contains both ApoB and HSP60 epitopes 
located at the same sites as they were in constructs A and H respectively. Both construct AHC and 
construct AHHC have the same N-terminal sequence as in construct A as well as in construct AH, but 
with an additional Cpn sequence in a combination form derived from the major outer membrane protein 
(MOMP) of the Cpn (peptide sequence: G
67
DYVFDRI
74
) and polymorphic outer membrane protein 
(Omp) 5 of Cpn (peptide sequence: Q
283
AVANGGAI
291
). Construct AHHC contains an additional epitope 
derived from hHSP60 (peptide sequence: P
303
GFGDNRKNQ
312
) in dendroaspin loop II. Schematic 
representation of constructs is shown in Figure S1B. 
 
The genes were synthesized by Genescript, USA Inc under confidential agreement and cloned into a 
PUC57 vector. A PCR was employed for producing the genes of constructs A, H, AH, AHC and AHHC 
converting a HindIII restriction site within PUC57 vector into an EcoRI site within pGEX-3X vector. The 
following primers were used: a forward primer with a BamHI cleavage site: 5’-GAA GGG ATC CAT 
ATC GAA GGT CGT ATC GAA ATC GGC-3’ and a reverse primer with an EcoRI site: 5’-TCA TCA 
CGA GAA TTC TCA AAG GTT GCA TTT GTC AGA TTC-3’ for genes in constructs A and AH; a 
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forward primer: 5’-GAA GGG ATC CAT ATC GAA GGT CGT CGT ATC TGC TAC-3’ and a same 
reverse prime as above was used for gene of construct H; a forward primer 5’-GAA GGG ATC CAT ATC 
GAA GGT CGTA TCG AAA TCG GC-3’ and a reverse primer: 5’-TCA TCA CGG GAA TTC TCA 
GAT AGC ACC ACC GTT AGC GAC AGC-3’ were used for producing both genes of construct AHC 
and construct AHHC. For the PCR reactions, 100 μl of reaction mixture prepared in either Taq 
polymerase reaction buffer (50 mM KCl; 10 mM Tris-HCl, pH 8.8; 1.5 mM MgCl2; 0.1 % Triton X-100) 
or Vent polymerase reaction buffer [10 mM KCl; 10 mM (NH4)2SO4; 20 mM Tris-HCl, pH 8.8; 2 mM 
MgSO4; 0.1 % Triton X-100] containing ddNTP (400 μM ), 300 ng of each oligonucleotide primer, 25–
100 ng cDNA template and 1.5–2 units of either Taq or Vent DNA polymerase were placed in a Perkin-
Elmer/Cetus Thermal Cycler (Norwalk, CT, USA). After initial denaturation of the DNA at 94
o
C for 2.5 
min, a cycle program was set: 40 cycles- 94
o
C for 45 seconds, 70
o
C for 2 minutes and 55
o
C for 2 minutes. 
After PCR, 10 μl of each reaction mixture was electrophoretized in an agarose gel and visualized by 
ethidium bromide staining to check the yield. The PCR fragments were digested by EcoRI and BamHI 
and gene-cleaned to separate DNA templates from the newly synthesized genes, and cloned into the 
carboxyl terminus of the glutathione S-transferase (GST) gene in the restricted vector pGEX-3X 
(Amersham Biosciences UK Limited). The genes were transformed into an E. coli DH5α strain. 
 
Dendroaspin contains four disulphide bridges and has an adaptable protein template that can be 
manipulated by the substitution and insertion of peptide sequences [2]. hHSP60153-163 was inserted into 
loop III of dendroaspin (11 amino-acid residues) in constructs H, AH, AHC and AHHC. Loop III was 
selected as a site for substitution since it is solvent-exposed and located away from other loops; 
consequently, with the exception of construct A, the Arg-Gly-Asp (RGD)-tripeptide thought to be an 
integrin-binding site and its flanking sequence [3] were substituted by hHSP60153-163 in all other 
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constructs. Although the RGD-tripeptide is not substituted in construct A, this tripeptide along with its 
flanking sequence do not contribute to lesion reduction, as immunization with a wild-type dendroaspin 
without coupled immunogen used was associated with the same grade of lesion as those in non-
immunized controls. In addition, we introduced an ApoB peptide sequence into the N-terminus of 
constructs A, AH, AHC and AHHC and not into the loops since we considered that its 20 residue length 
would be too great within each loop. Similarly, we attached a combination of Cpn peptide (26 residues) 
onto the C-terminals of construct AHC and AHHC. This combination of Cpn peptide was proved to be 
immunogenic and showed cross-reactivity in preliminary studies (see Figure 2 online supplement). In 
addition, we substituted loop II with hHSP60303-312 epitope in construct AHHC to determine whether this 
modification has an additional effect on the immune response in reducing the atherosclerotic lesions. The 
genes of constructs were cloned into a DNA vector PGEX-3X as a glutathione S-transferase-fusion 
protein for the purpose of increasing protein yield as well as for affinity purification.  
 
Transformation of E. coli DH5α and BL21 
The pGEX-3X vector with insertions of the genes of constructs A, H, AH, AHC and AHHC were used to 
transform 50 μl of E. coli DH5α (for preparing plasmid DNA) or BL21 (for protein expression) competent 
cell line by incubation on ice for 30 minutes followed by a heat shock of 20 s at 37
o
C. Following further 
2-minute incubation on ice, the cells were shaken at 37
o
C for 60 minutes in growth medium (1.0 ml) and 
were then plated. The positive colonies on the LB plate were screened by PCR. Presence of the correct 
coding sequence of gene was verified by dideoxy chain termination sequencing. 
 
Protein expression 
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Protein expression in E. coli was performed as described previously [2]. In brief, bacterial culture 
conditions were set up as follows; the 2xYT/ampicillin medium (100 μg/ml) was inoculated with an 
overnight seed culture (1%, v/v), it was shaken at 37
o
C until it reached an OD600 of 0.7. Isopropyl β-D-
thiogalactoside (IPTG) was then added to a final concentration of 0.1 mM for induction. The cells were 
grown for additional 4 hours at a low temperature of 30°C and harvested by centrifugation. 
 
Affinity and ion exchange chromatography 
GST-fusion constructs A, H, AH AHC, and AHHC were prepared from the sonicated cells of E. coli by 
affinity chromatography using glutathione-Sepharose 4B columns followed by DE50 ion-exchange 
chromatography. Purified GST-fusion proteins were analyzed by SDS-PAGE for homogeneity (Figure 
S1C). The working concentration of the GST-fusion proteins was determined by a combination of protein 
estimation with the Micro BCATM-Protein Assay Reagent kit (Pierce) with BSA as an internal standard 
and protein estimation on SDS-PAGE (BSA as a standard) analyzed by a Bio-Rad gel scanner (GelDoc 
2000).  
 
Animal experiments:  
Animals: Male Apob
tm2Sgy
Ldlr
tm1Her 
J mice, The Jackson Laboratory) were maintained under standard 
husbandry conditions at the animal facility of the Department of Medical Microbiology and 
Immunobiology, University of Szeged and were given food and water ad libitum. Mice were used with a 
total of 8 groups (5 sample groups and three control groups) and 6 mice (5-6 weeks old) in each group. 
The experiment was repeated. For sample groups, immunizing antigens used were constructs A, H, AH, 
AHC and AHHC. For antigen injection, the "repetitive immunization multiple sites strategy" (RIMMS) 
was adopted [4,5]. Mice were inoculated 5 times at 2-3-day intervals. At each immunization mice received 
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20 g protein combined with Aluminum hydroxide adjuvant (0.65 mg/mouse; Alum, Aluminum 
hydroxide gel from Sigma) in PBS with a final volume of 240 l. This mixture was distributed into 8 sites, 
30 l for each site [5]. Group 1 received construct A, group 2: construct H, group 3: construct AH, group 
4: construct AHC, group 5: construct AHHC, group 6-8 (control) were injected with the same dose of 
GST-dendroaspin mixed with Alum, Alum adjuvant, or Phosphate buffered saline (PBS), respectively. To 
study the cross-reaction between ApoB antigen and anti-Cpn peptide antibodies, or between Cpn-peptide 
and ApoB peptide antibodies, KLH-conjugated peptides were used. Mice were immunized with 20 g 
KLH-peptide conjugates in combination with Alum and using KLH with Alum as a control. Peptides were 
synthesized and conjugated to KLH by Severn Biotech Ltd, UK. Two weeks after the first antigen 
injection (RIMMS), sera were collected for ELISA test. 
 
The experiments were approved by the Animal Welfare Committee of the University of Szeged and 
conform with the Directive 2010/63/EU of the European Parliament. 
 
Plasma-lipoprotein analysis 
Plasma total cholesterol, triacylglycerol and high-density lipoprotein (HDL) were measured with a 
Moldular P800 assay system (Roche, Mannheim, Germany) through a service from the Department of 
Laboratory Medicine, University of Szeged, Hungary. Low-density lipoprotein (LDL) cholesterol was 
calculated according to the Friedewald formula:  
LDL concentration (mmol/L) = total cholesterol – (HDL + triacylglycerol  0.46). 
 
Antibody response measurement  
 6 
Blood samples were collected in heparinized capillaries by retro-orbital bleeding under pentobarbital 
sodium anesthesia at week two, and twelve weeks after the first injection of the antigens to test antibody 
production. The free ApoB-100 peptide, two different hHSP-60 peptides and Cpn peptide containing an 
N-terminal cysteine (synthesized by Severn Biotech Ltd, UK) were used in ELISA as antigens. Maleimide 
activated 96-well plates (Pierce, Thermo Fisher Scientific Inc., USA) were coated with these peptides 
individually and peptide-specific IgG was measured in the plasma of immunized mice according to the 
manufacturer’s instructions. Horseradish peroxidase-conjugated α-mouse IgG (Jackson ImmunoResearch 
Laboratories, Inc. West Grove, PA, USA) was used as secondary antibody. 1:100 dilution of plasma 
samples was made before assaying for peptide-specific IgG.  
 
Antibody cross-reaction measurement results 
Immunization with KLH-conjugated ApoB and hHSP60 peptides was described earlier [5]. Sera from 
these experiments and sera of Cpn peptide-immunized mice were used for testing cross-reaction of 
peptide-specific antibodies. ApoB, hHSP60 and Cpn peptides, individually, induced high levels of 
peptide-specific IgG in mouse sera two weeks after the first immunization compared to the control group 
immunized with KLH alone. A low level of cross-reaction was observed when antisera to Cpn were used 
against ApoB peptide antigen (Figure S2A). High cross-reaction was observed when antisera to ApoB 
peptide were used against Cpn peptide antigen (Figure S2B). These results show cross-reactions between 
ApoB and Cpn peptides which may be due to molecular mimicry. 
 
Tissue preparation  
Twelve weeks after the first immunization, hearts with proximal aortas were harvested and mounted in 
OCT or paraffin, for immunohistochemical analyses and lesion measurement, respectively. The OCT-
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embedded samples were frozen in the mounting medium (OCT compound, Tissue-Tek, Sakura Finetek, 
Europe) from which 5- m thick sequential sections were taken using a Reichert-Jung Cryocut 1800 
(Leica). The paraffin-embedded sections were prepared using a Leica Jung RM2055 microtome.  
 
Spleens were dissected and one third of spleen of each mouse was embedded in OCT for 
immunohistochemical analyses, two third of the spleen and axial and inguinal lymph nodes were homogenized 
by pressing through a 70 m nylon cell strainer and the cells were recovered in RPMI 1640 complete medium 
supplemented with 10% FCS, 100 U/ml penicillin and 100 g/ml streptomycin. 
 
Morphometric analyses and quantitative measurements of atherosclerosis  
Paraffin-embedded sections were cut serially at 8 m intervals from the aortic sinus and mounted on 
slides. Prior to section staining, sections were deparaffinized in xylene and rehydrated in graded series of 
ethanol. For area measurements and morphometric analysis, slides prepared from formalin sections were 
stained with hematoxylin and eosin (HE) and elastin/van Gieson (Sigma) for histological evaluation using 
an Olympus U-ULH optical microscope (Olympus Optical Co. Ltd, Japan). Image-Pro Plus TM software 
version 4.0 (Media Cybernetics, Silver Spring, USA) was used to trace the external elastic lamina, internal 
elastic lamina and lumen in the sections of aortic root area to ascertain area of atherosclerotic lesions. The 
total aortic root area and lesion area were measured following which the ratio of total lesion area/total 
aortic root area was calculated and expressed as % of lesion in aortic root area.  
 
The total cross-sectional aortic area (measured along the inner aortic perimeter) and lesion area were measured 
following which the ratio of total lesion area to total aortic lumen area was calculated and expressed as a 
percentage of lesion in the cross-section of the aortic root area.  
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Immunohistochemical analyses 
Hearts
 
with proximal aortas and spleens embedded in OCT were sectioned and sections with aortic sinus 
were fixed in methanol. Consecutive tissue sections were incubated in 0.2% TritonX-100/PBS for 1 hour 
then blocked with 1% BSA for 1 hour. The samples were stained with either purified hamster anti-mouse 
CD11c (eBioscience, Ltd., UK) or rat anti-mouse CD4 (BD Biosciences, UK), CD68, Foxp3 or TNF-α 
(BioLegend, USA) at 4°C overnight, washed in PBS and incubated with rabbit anti-rat IgG-FITC or goat 
anti-mouse IgG-TRITC (Sigma, UK). For IL-10 and for Foxp3 (BD Biosciences, UK), FITC-conjugated 
rat anti-mouse CD4 mAb and PE-labelled anti-mouse IL-10 and Foxp3 (BioLegend, San Diego, CA, 
USA) were used. All slides were counterstained with mounting medium containing DAPI (Vector 
Laboratories Inc., USA). Bright-field images were captured, scanned and overlaid using an Axiovert S100 
TV immunofluorescence microscope (Zeiss, UK) equipped with Plan-NEOFLUAR objectives and a 
KTL/CCD-1300/Y/HS camera from Princeton Instruments, USA. Image-Pro Plus TM software version 
4.0 was used to determine lesion area. The CD68
+
, CD11c
+
, Foxp3
+
 and CD4
+
 areas within the lesions and 
CD4+ areas in spleen sections were measured with a microscope averaged in m
2
. Three sections from each 
animal (six animals from each group) were investigated.  
 
Flow Cytometric Analysis 
The CD4
+
 T-cells from lymph nodes from recombinant construct- or GST-dendroaspin-immunized 
Apob
tm2Sgy
Ldlr
tm1Her 
J were used for detection of the level of Foxp3 expression using a Treg detection kit 
(MACS, catalog no. 130-094-165), according to   the manufacturer’s instructions. Cells were analyzed on 
a flow cytometer (Cytomics FC500; Bachman coulter, High Wycombe, UK).  
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Measurement of pro- and anti-inflammatory cytokines 
Levels of murine cytokines IL-10, TGF-β, TNF-α, and IFN-γ were measured in plasma using ELISA kits 
following the manufacturer’s instructions (R&D systems, Abingdon, UK). Levels of ConA-induced IL-10, 
TGF-β, TNF-  and IFN-γ in splenocyte cultures were measured. Briefly, 48-h spleen cell cultures of mice 
were stimulated with ConA (0, 1, 10,100 g/ml). The cells were cultured for additional 24-h after adding 
ConA. Cytokine supernatants were determined by sandwich ELISA as recommended by the manufacturer. 
IL-10 and TNF-α levels in the lesions were quantified by immunohistochemical analyses and the ratio of 
IL-10 and TNF-α positive area/total lesion area, respectively was measured and calculated by using 
Image-Pro Plus TM, version 4.0. 
 
CD4
+
 T-cell proliferation assay  
CD4
+ 
T-cells were purified from spleen cells of Apob
tm2Sgy
Ldlr
tm1Her 
J mice immunized with constructs A, 
H, AH, AHC and AHHC or with PBS (control) by using the magnetic-activated cell
 
sorting (MACS) 
CD4
+
 T-Cell Isolation Kit (Miltenyi Biotec) and used as responder cells. Constructs as antigens and γ- 
irradiated (30Gy) spleen cells from PBS-treated Apob
tm2Sgy
Ldlr
tm1Her 
J mice were used for stimulation. 
CD4
+
 T-cells (3x10
5
/well) were stimulated with γ- irradiated spleen cells (2x105/well) in the presence or 
absence of antigens (0.5 M) for 72 hours at 37 °C in a 5% CO2, 90% air-humidified incubator. Eighteen 
hours before harvesting, 0.5 μCi of methyl-[3H]-thymidine (Amersham Biosciences, Amersham, UK)/well 
were added into the cultures for the final 6 h. The cells were harvested and incorporated radioactivity was 
measured using a Micro 96 harvester (Skatron Instruments, Lier, Norway) and liquid scintillation counter 
(1205 BetaplateTM, Turku, Finland).  
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For antigen-specific regulatory function, CD4
+
CD25
+
 Treg cells were isolated from the spleen CD4
+
 T-
cells of Apob
tm2Sgy
Ldlr
tm1Her 
J mice immunized subcutaneously with the construct AHC. T-effector cells, 
CD4
+
CD25
−
 cells were isolated from the spleen CD4
+
 T-cells of mice immunized with the construct 
AHHC. CD4
+
CD25
−
 cells (2×10
5
) were co-cultured with CD4
+
CD25
+
 cells (2×10
5
), in the presence of 
2×10
4 
irradiated (3000 rad) splenocytes (as a source of antigen-presenting cells) per well, and stimulated 
with 1 μM of either construct A or H or with GST control, After 3 days of culture, cells were pulsed with 
0.5 μCi of [3H]thymidine (Amersham, Buckinghamshire, UK) for the last 18 hours of culture and then 
harvested, and the incorporation of [
3
H]thymidine was determined using a liquid scintillation spectroscopy 
method (1205 BetaplateTM, Turku, Finland).  
 
Statistical analyses  
Data are reported as mean±standard error of the mean (±SEM), unless otherwise indicated. Figures were 
plotted using graph-pad Prism 5.01 and Sigma plot 9.0. For atherosclerotic lesion size, data were 
compared and intergroup differences were conducted using one-way ANOVA for multiple comparisons 
and post hoc bonferroni test. Others data were analyzed using Student’s t-test (2-tailed analyses). Non-
parametric distributions were analysized using Mann-Whitney U test for pairwise comparisons and the 
Kruskal-Wallis test for multiple comparisons. Differences between groups were considered significant at 
P values below 0.05. 
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Figure S1 
 
 
 
 
 13 
 
 
 
Fig. S1: Schematic representation of the backbone of the dendroaspin structure [1] (A). Schematic 
representation of alignment of constructs H, A, AH, AHC and AHHC and dendroaspin scaffold (B). 
SDS-PAGE analysis (15%, w/v gel) of protein purification (C). Column 1, 4, 7, 11 and 14 are 
supernatants before the affinity and ion exchange purification; column 2, 5, 8, 12 and 15 purified by 
affinity column; and 3, 6, 9, 10,13 and 16 were further purified by ion exchange column. R.P denotes 
recombinant protein; GST denotes glutathione-S-transferase which was used as a protein tag for 
protein expression and purification.  
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Figure S2 
 
            
     
 
 
 
 
 
Figure S2 Cross-reactivity assays: peptide-induced specific IgG levels of pooled plasma samples from 
male mice at week 2 were measured by OD. The mean ODs obtained from plasma samples of Control 
mice (immunized with KLH) and sampling mice on ApoB peptide- and Cpn peptide-coated ELISA plates, 
respectively, dilution ratio: 1:100 as shown in Figure S2 A and B.  
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Figure S3 
 
 Figure S3:  Photomicrograph of lesions observed in atherosclerotic aortas of mice in control groups as 
analyzed with elastin/van Gieson staining ((N=18sections). 
 
 16 
Table S1 
                                                                   Lipid levels in pooled plasma 
    
Calculated 
values 
Body weight 
at 10 weeks 
with feeding 
HFD 
Groups 
Cholesterol 
(mmol/l) 
Triglyceride 
(mmol/l) 
HDL-
cholesterol 
(mmol/l) 
LDL-
cholesterol 
(mmol/l) 
 
(g) 
A 34.57 2.52 5.24 28.18 
 
 
21.73±1.29 
H 31.39 2.14 4.61 25.81 
 
20.35±0.60 
AH 31.98 2.08 4.88 26.15 
 
20.26±2.12 
AHC 30.68 2.6 4.94 24.56 
 
20.93±2.73 
AHHC 34.54 2.79 5.12 28.15 
 
20.38±1.06 
GST-den 34.96 2.08 5.11 28.46 
 
20.71±2.75 
PBS 29.83 2.45 4.91         24.04 
 
19.7±2.32 
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Figure S4 
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Figure S4: Statistical analysis of IL-10, TGF-  and Foxp3 expression levels in lesions, plasma samples 
and splenocyte supernatants in correlation with lesion occupied area in aorta sinus (plotted and analyzed 
using Prism version 5 software).  
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Figure S5 
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Figure S5: Analysis of the proliferative response of CD4+ T-cells isolated from the spleen of ApoB100 only, 
LDLr
-/-
 mice fed a high-fat diet after immunization with constructs A, H, AH, AHC and AHHC after 
stimulation with appropriate construct. [
3
H]-thymidine incorporation was detected in triplicate cultures and 
counts (cpm) and SEM are shown. 
A: CD4
+
 T-cells from PBS-treated mice were tested with both constructs. 
B: CD4
+
 T-cells from construct A-immunized mice were stimulated with both constructs A and H showing 
significant response to construct A and no response to construct H.  
C: CD4
+
 T-cells from construct H-immunized mice were stimulated with both constructs A and H showing 
significant response to construct H and no response to construct A. 
D: CD4
+
 T-cells from construct AH-immunized mice were stimulated with AH showing significant response to 
AH  
E: CD4+ T-cells from construct AHC-immunized mice were stimulated with AHC showing significant response 
to AHC.  
F: CD4+ T-cells from construct AHHC-immunized mice were stimulated with AHHC showing significant 
response to AHHC.  
 
